Profil
Heather Dale Jones is currently working as an Associate Clinical Professor at David Geffen School of Medicine.
Previously, she worked as the Director-Lung Imaging & Associate Professor at Cedars-Sinai Medical Center and as the Vice President-Clinical Development at Armata Pharmaceuticals, Inc. Dr. Jones completed her undergraduate degree at the University of California, Berkeley and her doctorate at Hahnemann University.
Aktiva positioner av Heather Dale Jones
| Företag | Position | Start |
|---|---|---|
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Tidigare kända positioner av Heather Dale Jones
| Företag | Position | Slut |
|---|---|---|
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Företagsledare/Principal | - |
| ARMATA PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Heather Dale Joness utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Operates as a hospital | Health Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hahnemann University
Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
















